Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Japanese rights to bevacizumab and pertuzumab licensed to Chugai

Dec. 17, 2003

Targent acquires dibromodulcitol

Dec. 17, 2003

Novacea licenses North American rights to AQ4N

Dec. 17, 2003

Praecis collaborates with NCI on PPI-2458

Dec. 16, 2003

Avanir and Peregrine execute license agreement for antibody

Dec. 16, 2003

Phase I trial commences for CNTO-95

Dec. 16, 2003

Monoclonal antibody targeting CD44 induces differentiation and apoptosis in AML cells

Dec. 15, 2003

EiRx to evaluate SR Pharma's inositol phosphoglycans

Dec. 15, 2003

Novel Pin1 inhibitors designed and tested by German researchers

Dec. 15, 2003

Roche researchers prepare and test new dimeric antitumor agents

Dec. 15, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...